These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4796448)

  • 1. The role of telencephalic dopaminergic systems in the mediation of apomorphine-stereotyped behaviour.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1973 Oct; 24(1):8-24. PubMed ID: 4796448
    [No Abstract]   [Full Text] [Related]  

  • 2. Contributions of Philip Teitelbaum to affective neuroscience.
    Berridge KC
    Behav Brain Res; 2012 Jun; 231(2):396-403. PubMed ID: 22051942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychomotor effect differences between l-methamphetamine and d-methamphetamine are independent of murine plasma and brain pharmacokinetics profiles.
    Nishimura T; Takahata K; Kosugi Y; Tanabe T; Muraoka S
    J Neural Transm (Vienna); 2017 May; 124(5):519-523. PubMed ID: 28213761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Judgment Bias Interacts with Risk Based Decision Making and Sensitivity to Dopaminergic Challenge in Male Rats.
    Drozd R; Cieslak PE; Rychlik M; Rodriguez Parkitna J; Rygula R
    Front Behav Neurosci; 2016; 10():163. PubMed ID: 27601984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment or Posttreatment with Aripiprazole Attenuates Methamphetamine-induced Stereotyped Behavior in Mice.
    Kitanaka N; Kitanaka J; Hall FS; Kayama M; Sugimori H; Uhl GR; Takemura M
    J Exp Neurosci; 2015; 9(Suppl 1):1-10. PubMed ID: 26525833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride.
    Martelle JL; Nader MA
    CNS Neurosci Ther; 2008; 14(3):248-62. PubMed ID: 18801115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on electroencephalogram (EEG) in rats suggest that moderate doses of cocaine or d-amphetamine activate D1 rather than D2 receptors.
    Ferger B; Kropf W; Kuschinsky K
    Psychopharmacology (Berl); 1994 Mar; 114(2):297-308. PubMed ID: 7838923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of morphine on EEG in rats and their possible relations to hypo- and hyperkinesia.
    Ferger B; Kuschinsky K
    Psychopharmacology (Berl); 1995 Jan; 117(2):200-7. PubMed ID: 7753968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine and cerebral cortical blood flow in the rat.
    Rovere AA; Raynald AC
    Experientia; 1980 May; 36(5):577-8. PubMed ID: 7379961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies.
    Köhler C; Haglund L; Ogren SO; Angeby T
    J Neural Transm; 1981; 52(3):163-73. PubMed ID: 7198139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural effects of electrolytic and 6-hydroxydopamine lesions of the accumbens and caudate-putamen nuclei.
    Makanjuola RO; Ashcroft GW
    Psychopharmacology (Berl); 1982; 76(4):33-40. PubMed ID: 6812107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of brain dopaminergic mechanisms in rodent aggressive behavior: influence of (+/-)N-n-propyl-norapomorphine on three experimental models.
    Baggio G; Ferrari F
    Psychopharmacology (Berl); 1980; 70(1):63-8. PubMed ID: 6775337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of dopamine antagonists discriminating various behavioral responses and radioligand binding sites.
    Martres MP; Sokoloff P; Delandre M; Schwartz JC; Protais P; Costentin J
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):102-15. PubMed ID: 6144046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect?
    Costall B; Naylor RJ
    Psychopharmacologia; 1973; 32(2):161-70. PubMed ID: 4796282
    [No Abstract]   [Full Text] [Related]  

  • 15. A role for the amygdala in the development of the cataleptic and stereotypic actions of the narcotic agonists and antagonists in the rat.
    Costall B; Naylor RJ
    Psychopharmacologia; 1974 Feb; 35(3):203-13. PubMed ID: 4597802
    [No Abstract]   [Full Text] [Related]  

  • 16. On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity.
    Costall B; Naylor RJ
    Psychopharmacologia; 1974 Jan; 34(3):233-41. PubMed ID: 4594816
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of catecholaminergic mechanisms in the expression of the morphine abstinence syndrome in rats.
    Herz A; Bläsig J; Papeschi R
    Psychopharmacologia; 1974; 39(2):121-43. PubMed ID: 4476079
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in dopamine agonist and antagonist activity following temporary inactivation of the neostraitum.
    Costall B; Naylor RJ; Pettit JC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(2):103-26. PubMed ID: 4281065
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific asymmetric behavior induced by the direct chemical stimulation of neostriatal dopaminergic mechanisms.
    Costall B; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(1):83-98. PubMed ID: 4280020
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine agonist and antagonist activities of piribedil (ET495)and its metabolites.
    Costall B; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(1):71-81. PubMed ID: 4280019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.